• Caini, S., Huang, Q.S., Ciblak, M.A., Kusznierz, G., Owen, R., Wangchuk, S., Henriques, C.M., Njouom, R., Fasce, R.A., Yu, H., Feng, L., Zambon, M., Clara, A.W., Kosasih, H., Puzelli, S., Kadjo, H.A., Emukule, G., Heraud, J.M., Ang, L.W., Venter, M., Mironenko, A., Brammer,L., Maile, T.Q., Schellevis,F., Plotkin,S., Paget,J., Global Influenza,B.S., 2015. Epidemiological and virological characteristics of influenza b: results of the global influenza b study. Influenza Other Respir. Viruses 9 (Suppl. 1), 3–12.

  • Corti, D., Lanzavecchia, A., 2013. Broadly neutralizing antiviral antibodies. Annu. Rev. Immunol. 31, 705–742.

  • Iglesias-Ussel, M.D., Fan, M., Li, Z., Martin, A., Scharff, M.D., 2006. Forced expression of aid facilitates the isolation of class switch variants from hybridoma cells. J. Immunol. Methods 316, 59–66.

  • Ku, Z., Xie, X., Hinton, P.R., Liu, X., Ye, X., Muruato, A.E., Ng, D.C., Biswas, S., Zou, J., Liu, Y., Pandya, D., Menachery, V.D., Rahman, S., Cao, Y.A., Deng, H., Xiong, W., Carlin, K.B., Liu, J., Su, H., Haanes, E.J., Keyt, B.A., Zhang, N., Carroll, S.F., Shi, P.Y., An, Z., 2021. Nasal delivery of an igm offers broad protection from sars-cov-2 variants. Nature 595, 718–723.

  • Pan, Y., Zhang, Y., Yang, P., Qian, H., Shi, W., Wu, S., Cui, S., Zhang, D., Wang, Q., 2015. Epidemiological and phylogenetic characteristics of influenza b infection in severe acute respiratory infection cases in beijing, 2014 to 2015. Medicine (Baltim.) 94, e2399.

  • Shen, C., Zhang, M., Chen, Y., Zhang, L., Wang, G., Chen, J., Chen, S., Li, Z., Wei, F., Chen, J., Yang, K., Guo, S., Wang, Y., Zheng, Q., Yu, H., Luo, W., Zhang, J., Chen, H., Chen, Y., Xia, N., 2019. An igm antibody targeting the receptor binding site of influenza b blocks viral infection with great breadth and potency. Theranostics 9, 210–231.

  • Stavnezer, J., Guikema, J.E., Schrader, C.E., 2008. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26, 261–292.

  • Su, Y.C., Al-Qaisi, T.S., Tung, H.Y., Cheng, T.L., Chuang, K.H., Chen, B.M., Roffler, S.R., 2014. Mimicking the germinal center reaction in hybridoma cells to isolate temperature-selective anti-peg antibodies. mAbs 6, 1069–1083.

  • Subbarao, K., Matsuoka, Y., 2013. The prospects and challenges of universal vaccines for influenza. Trends Microbiol 21, 350–358.

  • van de Sandt, C.E., Bodewes, R., Rimmelzwaan, G.F., de Vries, R.D., 2015. Influenza b viruses: not to be discounted. Future Microbiol 10, 1447–1465.

  • Walker, L.M., Burton, D.R., 2018. Passive immunotherapy of viral infections: ‘Superantibodies’ enter the fray. Nat. Rev. Immunol. 18, 297–308.

  • Wilson, P.C., Andrews, S.F., 2012. Tools to therapeutically harness the human antibody response. Nat. Rev. Immunol. 12, 709–719.

  • Yerabham, A., Ho, M., 2021. A novel igm intranasal intervention against sars-cov-2. Antib. Ther. 4, 171–174.